A B S T R A C T Thyroid disease is often accompanied by changes in the concentrations of serum lipids and lipoproteins. To evaluate the hepatic contribution to the serum abnormalities in thyroid disease, we examined fatty acid metabolism in perfused livers from pair-fed rats made hypothyroid with propylthiouracil (PTU) or made hyperthyroid by treatment with triiodothyronine (T3). The animals treated with T3 became hyperphagic, depending on dose of drug and duration of hyperthyroidism. It was necessary, therefore, for appropriate controls, that food intake of T3-treated rats be restricted to quantities consumed by euthyroid rats. Animals treated with PTU for 2 wk became hypophagic, and therefore, food consumption of controls was restricted to that eaten by rats receiving PTU. Dependent on dose of T3 and duration of treatment, the output of triglyceride and glucose was diminished, whereas output of ketone bodies was increased by livers from hyperthyroid animals. In contrast, livers from PTUtreated animals secreted increased amounts of triglyceride and glucose, whereas ketogenesis was diminished. The best models for study proved to be animals treated with either 10 gg T3/100 g body wt per d or 1 mg PTU/100 g body wt per d for 7 d. Under these conditions, all animals consumed the same quantity of food as did the euthyroid rats, but continued to display the metabolic alterations outlined above. The effects of PTU on hepatic metabolism were readily reversible by simultaneous administration ofT3. It is clear from these data that the thyroid status of the rat regulates hepatic triglyceride formation and secretion, and ketogenesis.
A B S T R A C T Thyroid disease is often accompanied by changes in the concentrations of serum lipids and lipoproteins. To evaluate the hepatic contribution to the serum abnormalities in thyroid disease, we examined fatty acid metabolism in perfused livers from pair-fed rats made hypothyroid with propylthiouracil (PTU) or made hyperthyroid by treatment with triiodothyronine (T3). The animals treated with T3 became hyperphagic, depending on dose of drug and duration of hyperthyroidism. It was necessary, therefore, for appropriate controls, that food intake of T3-treated rats be restricted to quantities consumed by euthyroid rats. Animals treated with PTU for 2 wk became hypophagic, and therefore, food consumption of controls was restricted to that eaten by rats receiving PTU. Dependent on dose of T3 and duration of treatment, the output of triglyceride and glucose was diminished, whereas output of ketone bodies was increased by livers from hyperthyroid animals. In contrast, livers from PTUtreated animals secreted increased amounts of triglyceride and glucose, whereas ketogenesis was diminished. The best models for study proved to be animals treated with either 10 gg T3/100 g body wt per d or 1 mg PTU/100 g body wt per d for 7 d. Under these conditions, all animals consumed the same quantity of food as did the euthyroid rats, but continued to display the metabolic alterations outlined above. The effects of PTU on hepatic metabolism were readily reversible by simultaneous administration ofT3. It is clear from these data that the thyroid status of the rat regulates hepatic triglyceride formation and secretion, and ketogenesis. INTRODUCTION Alterations in thyroid status appear to be associated with changes in serum triglyceride concentrations. In human hyperthyroidism, decreased (1) , normal (2) (3) (4) , and increased (5) serum concentrations of triglyceride have been observed. Concentrations ofserum triglyceride, although usually elevated in human hypothyroidism (1) (2) (3) (5) (6) (7) (8) (9) , have also been reported to be normal (10, 11) . When hypothyroid subjects were treated with thyroid hormone preparations, the serum triglyceride concentration returned toward normal (2, 7, 9) , although exceptions were reported (8) . Similarly, when euthyroid hypertriglyceridemic subjects were administered thyroid hormone or thyroid hormone analogues, there was usually a reduction in serum triglyceride values (12) . Because hypertriglyceridemia was not as consistent a finding in hypothyroidism as was hypercholesterolemia (10, 13) , it has been postulated that the degree of hypertriglyceridemia was related to the severity or duration (6, 11) of hypothyroidism as well as to the diet (7) .
The serum triglyceride concentration is regulated by entry of triglyceride into the serum from the diet in the form of chylomicrons, by hepatic synthesis and secretion of the very low density lipoprotein (VLDL),1 and by removal of VLDL and chylomicron triglyceride from the serum by lipoprotein lipase. Serum triglyceride concentration is regulated in postabsorptive animals to a significant extent by hepatic synthesis and secretion of VLDL triglyceride from FFA substrate. The present study was designed to determine effects of hyperthyroidism and hypothyroidism on the metabolism of FFA, on output of triglyceride, and on ketogenesis by the isolated perfused rat liver.
METHODS
Male Sprague-Dawley rats (Charles River Breeding Laboratories, Wilmington, Mass.) having initial weights of 150-175 g 'Abbreviations used in this paper: cAMP, cyclic AMP; PTU, propylthiouracil; T3, 3,5,3'-triiodothyronine; VLDL, very low density lipoprotein.
were housed in individual wire-bottom metabolic cages. Lighting was maintained between 0500 and 1700 h. The animals received daily subcutaneous injections of propylthiouracil (PTU), triiodothyronine (T3), or PTU and T3 between 1400 and 1600 h. When both drugs were given to the same animal, PTU and T3 were injected at separate sites. PTU and T3 were dissolved in 0.9% NaCl with 1 N NaOH, and the pH was adjusted to 8.5. Control (euthyroid) animals received injections of an equivalent volume of the vehicle at the same pH.
Rats treated with PTU (1.0 mg/100 g body wt per d) became hypophagic -8-10 d after start of treatment. To assure equicaloric consumption of food (powdered Purina Lab Chow, Ralston Purina Co., St. Louis, Mo.) pair-feeding procedures were necessary. Therefore, food allowed the control animals was restricted to the amount consumed by the PTU-treated group. Rats treated with T3 for 14 d became hyperphagic, but the onset of hyperphagia was dose related. Treatment with 1 ,ig T3/100 g body wt or less daily for 14 d did not affect food consumption and these animals were fed ad lib. At higher doses ofT3, animals were pair-fed to the intake ofthe euthyroid animals.
At the end of the treatment periods, the rats were anesthetized with diethyl ether between 0900 and 1100 h. The livers were isolated surgically and perfused in vitro using procedures and apparatus described previously (14) . Immediately before cannulation of the portal vein, 5 ml of blood was obtained with a heparinized syringe from the abdominal aorta of the rat. Bovine erythrocytes for the perfusate were collected by venipuncture and were washed according to the method of Exton et al. (15) , except that antibiotics were omitted from the anticoagulant collection medium. The washed erythrocytes were suspended in Krebs-Henseleit bicarbonate buffer (pH 7.4), 3 g/dl bovine serum albumin and 100 mg/dl glucose. The initial volume was 70 ml and the hematocrit was 30% (vol/vol). The medium was gassed continuously with 95%02-5% CO2. After a 20-min equilibration period, a complex containing 3 g bovine serum albumin and 1,419 ,umol oleic acid/dl (15) was infused at a rate of 11.7 ml/h (166 tmmol oleic acid/h). 5-ml samples of the perfusate were removed for analysis at hourly intervals. The experiment was terminated after 4 h of perfusion. The liver was perfused with 20 ml of ice cold 0.9% NaCl to remove residual perfusate, cleansed of adherent nonhepatic tissue, blotted, and weighed.
Lipids were extracted from the plasma-and erythrocyte-free perfusate (16) . The extracts were washed, fractionated, and the lipids analyzed as reported elsewhere (17) . Samples of the perfusate were hemolyzed and deproteinized with Ba(OH)2-ZnSO4; aliquots of the protein-free supemate were analyzed for ketone bodies (17) and glucose (glucose oxidase method, Boehringer Mannheim Biochemicals, Indianapolis, Ind.). Output oftriglyceride, ketone bodies, and glucose, and uptake of FFA were calculated as described previously (17) .
All chemicals used were reagent grade and all solvents were redistilled before use. 6-N-Propyl-2-thiouracil and L-T3, Na salt, were obtained from Sigma Chemical Co., St. Louis, Mo. Oleic acid (99% purity) was obtained from NuChek-Prep., Elysian, Minn. Bovine serum albumin (Fraction V powder), obtained from Pentex Biochemical, Kankakee, Ill., was purified before use (18) .
Statistical analyses were performed using computerized routines (19) . Perfusion parameters from the T3 dose-response study were analyzed using multiple regression analysis. The chemical data from the T3 dose-response experiments were analyzed using Kendall's tau (20) . In both instances the doses of T3 were transformed to log dose, to express the data in a linear fashion, before statistical analyses were performed. Hourly output data were analyzed using the Student's t test, except when multiple treatmenit groups were compared to the control. In those instances Dunnett's t test was employed (21) .
Variations of experimental samples from conitrol samples with a P value of <0.05 were considered statistically significant. Statistical significance is indicated in the figures by the use of asterisks: *, P < 0.05; **, P < 0.01; and ***, P < 0.001.
RESULTS
Body weights of animals in all treatimient groups were similar precediing treatment with T3 or PTU. During the 14-d treatment period, all animals gained weight. The gain in body weight, however, decreased with increasing dose of T3 ( Fig. 1) , liver weight also decreased with dose of T3. The ratio of liver weight to body weight, perfusate flow rate, and the volume of bile secreted were unchainged by treatment with T3. Animilals receiving T3 (3 ,ug/100 g body wt) plus PTU were similar in all of the al)ove parameters to aniiimals receiving the T3 alone, or to those treated with 0.9% NaCl only and maintained on identical food intake. The values for animal weight, liver weight, liver weight to body weight ratio, and perfusate flow rate for a separate group of pair-fed animals were not different from those recorded for rats treated with PTU for 14 d. The volume of bile secreted by the livers from PTU-treated animals was less than that seen in the controls. Other than a slight increase in perfusate flow rate (P < 0.01) in livers from animals treated with 10 ,ug TJ100 g body wt per d for 7 d, perfusion parameters were similar to the controls, perfusate flow rate was 3.0±0.2 ml/min per g liver in livers from the control rats and 3.9+0.1 ml/min per g liver for T3 treated aniiimals. All perfusion parameters were similar for animals treated with either T3 or PTU for only 3 
The results of treatment of rats with T3 on FFA uptake, triglyceride output, ketone body production, and glucose output are seen in Fig. 2 . These initial experiments were carried out with livers obtained from rats treated with either 0.9% NaCl or 5 ,ug T3/100 g body wt per d for 14 d. The control animals were fed ad lib. and the T3-treated animals were pair-fed to the amount of food consumed by the control animals. The uptake of FFA was unaffected by treatment with 5 ug T3/100 g body wt. The concentration of FFA in the cell-free medium perfusing livers from T3-treated animals (0.44 ±0.06 mM) was not different from that observed wit{{ controls (0.56±0.04 mM). However, output oftriglyceride and glucose were reduced 50% and the production of ketone bodies was augmented. To determine the dependency of these changes in hepatic metabolism on dose of T3, different groups of animals were treated for 14 duced changes in food consumption. Pair-feeding was therefore required. Doses of T3 are in ,ugl100 g body wt per d, whereas PTU dose was 1.0 mg/100 g body wt per d. Weights ofrats before drug treatment were 150-175 g, and were similar for all groups. With increasing dose of T3, the animal weight (P < 0.05) and liver weight (P < 0.05) at time of perfusion decreased. The doses of T3 and number of observations in each group were: 0 ,ug, n = 4; 0.5 ,ug, n = 3; 1 ug, n = 4, 3 ,ug, n = 4; 5 ,ug, n = 4; 10 ,ug, n = 2; 20 ,ug, n = 2. The number of observations per dose of PTU were: 0 mg, n = 6, (Fig. 4) euthyroid ad lib. fed controls that were appropriate for the T3 dose-response curve. It was necessary therefore, that a separate group of euthyroid conitrol animals be pair-fed to the decreased amounts of food consumed by the PTU-treated animals. As can be seein in Fig. 5 , treatment of the rat with PTU for 14 d did not affect uptake of FFA by the liver or concentrationi of FFA in the cell-free perfusate. Output of triglyceride however, was increased -250% whereas ketogenesis was -40% of the control. Output of glucose increased m()500% after treatment with PTU.
Under our experimental conditionis, the degree of hyperthyroidism was determined by the dose-time relationship of T3 administered. Varying degrees of hypothyroidismii were produced by changing the duration of Thyroid Status and Hepatic Lipid Metabolism treatment at constant dose of PTU, since the dose of PTU used inhibits essentially the total synthesis of thyroid hormones (22) ; the severity of the hypothyroidism is governed by the time required for clearance of the preexisting thyroid hormones from the body (23) . For this reason, the effects on hepatic lipid metabolism of duration of treatment at constant dose of PTU were examined. Livers from pair-fed animals treated for 3, 7, or 14 d with 0.9% NaCl or PTU were studied. The decrease in food consumption in the PTU-treated animals was not observed until 8-10 d after treatment was started; before that time, control and PTU-treated animals ate similar amounts of food. Hepatic uptake of FFA and concentration of FFA in the cell-free perfusate was not altered regardless of duration oftreatment with PTU (Fig. 6) . Output of triglyceride was increased after the 7-d treatment whereas food consumption was still unaffected. After the 14-d treatment the effect of decreased food consumption (partial fasting in the control) is to reduce triglyceride output by livers from both control and PTU-treated animals, since they are pairfed. Superimposed on the nutritional changes are the :r UPTAKE F FREE FATTY ACID stimulation of triglyceride secretion. In the following experiments, therefore, T3 was administered concurrently with PTU to rats to determine whether hypofunction of the thyroid was indeed the cause of the metabolic changes induced by PTU. The dose of T3 used in these experiments with PTU was 3 ,ug/100 g body wt, daily for 14 d. As seen in Table I , this dose of T3 was sufficient, even with simultaneous PTU treatment, to produce the metabolic alterations of hyperthyroidism. In separate experiments, PTU was added initially to the medium perfusing livers (n = 2) from normal fed male animals, and was also infused with the FFA complex to give a constant concentration of 1 mM (assuming no hepatic metabolism of PTU). When compared with perfusions to which an equal volume of 0.9% NaCl was added (n = 2), no differences in FFA uptake, or output of triglyceride, ketone bodies, or glucose were observed. Similarly, in other experiments, T3 was added to the perfusate and was infused with the FFA complex to maintain constant concentrations of 100 ,uM (n = 2) and 1 mM (n = 2) (assuming no hepatic metabolism of T3). Again, there were no obvious differences in any of the parameters measured. Because hepatic output of triglyceride is particularly sensitive to reduction in caloric intake, the best model for studying the metabolic effects of hypothyroidism or hyperthyroidism proved to be livers from animals treated for 7 d with either PTU or 10 ,ug T3/100 g body wt. Under these conditions, food consumption was unaffected. Concentrations of FFA in the cell-free medium perfusing livers from these rats were similar; neither FFA uptake, which was linear with time, nor FFA concentration was altered by treatment with PTU or T3 (Fig. 7) . The output of triglyceride, however, was increased about 2 ,mmol/g liver per 4 h with livers from PTU-treated animals and decreased about the same amount with livers from T3-treated rats. Ketogenesis was increased in the T3-treated animal, but was not altered from control in the PTU-treated rat under these experimental conditions. Similarly, glucose output was depressed in the T3-treated rats, but was not altered in the PTU-treated animal.
The concentration of FFA and triglyceride in plas'ma of the animals treated with 0.9% NaCl, PTU, or 10 lag T3/100 g body wt for 7 d was measured in samples obtained at the time of surgery. The concentrations of triglyceride were 0.33+0.07, 0.53+0.03, and 0.53+0.06
,umol/ml plasma for T3 (10 ug/100 g body wt), 0.9% NaCl, and PTU-treated animals, respectively. Corresponding concentrations of FFA were 0.45+0.03, 0.22 +0.01, and 0.34+0.03 ,umol/ml plasma for the T3, control, and PTU-treated animals, respectively. The elevation of plasma FFA (P < 0.05) and decrease in plasma triglyceride concentration (P < 0.05) in T3-treated rats differed significantly from the controls.
DISCUSSION
The thyroid status of the animal clearly is an important regulator of hepatic metabolism of FFA. When perfused with equimolar physiologic quantities of FFA (oleate), livers from PTU-treated animals secreted more triglyceride whereas livers from T3-treated animals secreted less triglyceride than did the respective euthyroid controls, despite the fact that uptake of FFA and concentration of FFA in the cell-free perfusate were equal in all groups. Conversely, but dependent on experimental conditions, ketogenesis was stimulated in the livers from animals treated with T3 and diminished in the livers from animals treated with PTU. In recent experiments2 using perfused livers from rats treated with PTU (1.0 mg/100 g body wt per d) or T3 (10 ug/100 g body wt per day) for 7 d, the proportion of [ (24, 26) , a] versial (27) . Diamant 
